| 1 |
Lang T, Streeper T, Cawthon P, et al. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int, 2010, 21(4): 543-559.
|
| 2 |
Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" . Clin Nutr, 2010, 29(2): 154-159.
|
| 3 |
Novak LP. Aging, total body potassium, fat free-mass, and cell mass in males and females between ages 18 and 85 years. J Gerontol, 1972, 24: 438-459.
|
| 4 |
Rogers MA, Evans WJ. Changes in skeletal muscle with aging: effects of exercise training. Exerc Sport Sci Rev, 1993, 21: 65-102.
|
| 5 |
Hughes VA, Frontera WR, Wood M, et al. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci, 2001, 56(5): B209-217.
|
| 6 |
Visser M, Kritchevsky SB, Goodpaster BH, et al. Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study. J Am Geriatr Soc, 2002, 50(5): 897-904.
|
| 7 |
Fischman AJ, Yu YM, Livni E, et al. Muscle protein synthesis by positron-emission tomography with L-[methyl-11C]methionine in adult humans. Proc Natl Acad Sci USA, 1998, 95(22): 12793-12798.
|
| 8 |
Frontera WR, Meredith CN, O'Reilly KP, et al. Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol, 1988, 64(3): 1038-1044.
|
| 9 |
Charette SL, McEvoy L, Pyka G, et al. Muscle hypertrophy response to resistance training in older women. J Appl Physiol, 1991, 70(5): 1912-1916.
|
| 10 |
Henwood TR, Taaffe DR. Detraining and retraining in older adults following long-term muscle power or muscle strength specific training. J Gerontol A Biol Sci Med Sci, 2008, 63(7): 751-758.
|
| 11 |
Galv?o DA, Taaffe DR, Spry N, et al. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol, 2010, 28(2): 340-347.
|
| 12 |
Borst SE. Interventions for sarcopenia and muscle weakness in older people. Age Ageing, 2004, 33(6): 548-555.
|
| 13 |
Perrini S, Laviola L, Carreira MC, et al. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol, 2010, 205(3): 201-210.
|
| 14 |
Boonen S, Rosen C, Bouillon R, et al. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J Clin Endocrinol Metab, 2002, 87(4): 1593-1599.
|
| 15 |
Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc, 2010, 11(6): 391-396.
|